SC
GWPH

Scholtz & Company’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Scholtz & Company’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-21,135
Closed -$3.65M – 63
2018
Q3 		$3.65M Buy
+21,135
New +$3.05M 2.3% 17

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Scholtz & Company's GWPH Position: Q4 2018 in Review

Scholtz & Company sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2018, closing a stake of 21,135 shares — an estimated $3.65M sold.

Scholtz & Company first reported a position in GWPH in Q3 2018 and held it in 1 quarter. The position peaked at $3.65M in Q3 2018. 277 funds tracked by Wall St. Rank hold GWPH as of Q4 2018.

  • Scholtz & Company reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2018 after selling out during the quarter.
  • Scholtz & Company sold 21,135 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2018, an estimated $3.65M.
  • Scholtz & Company first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2018 and held it in 1 quarter.
  • Scholtz & Company's GW Pharmaceuticals Plc American Depositary Shares position peaked at $3.65M in Q3 2018.
  • 277 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2018.

Based on Scholtz & Company's 13F filing for Q4 2018, filed 29 Jan 2019.